KLRS
Kalaris Therapeutics
KLRS
KLRS
94 hedge funds and large institutions have $184M invested in Kalaris Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 1.84% → 2.07% (+0.22%)
22% less call options, than puts
Call options by funds: $172K | Put options by funds: $221K
Holders
94
Holding in Top 10
–
Calls
$172K
Puts
$221K
Top Buyers
| 1 | +$18.3M | |
| 2 | +$7.32M | |
| 3 | +$3.47M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$2.62M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
+$2.5M |
Top Sellers
| 1 | -$955K | |
| 2 | -$478K | |
| 3 | -$238K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$231K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$188K |